Skip to main content
. 2020 Dec 9;133(7-8):292–297. doi: 10.1007/s00508-020-01780-0

Table 2.

COVID-19-suspected signs and symptoms at baseline and after oseltamivir treatment

Baseline 7 days P value
Fever, n (%) 16 (100) 0 (0) <0.001
Myalgia or fatigue, n (%) 13 (81) 1 (6) <0.001
Sore throat, n (%) 13 (81) 2 (13) <0.001
Cough, n (%) 11 (69) 3 (19) <0.001
Chills, n (%) 6 (38) 0 (0) <0.01
Headache, n (%) 6 (38) 0 (0) <0.01
Diarrhea, n (%) 4 (25) 2 (13) 0.33
Sputum production, n (%) 3 (19) 3 (19) 1.00
Dyspnea, n (%) 2 (13) 0 (0) 0.16
Appetite loss, n (%) 2 (13) 1 (6) 0.58
Nausea or vomiting, n (%) 1 (6) 0 (0) 0.33